Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364779 · ClinicalTrials.gov registry record
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 15
- Enrollment target
NCT01364779: Completed study, sponsored by Northwell Health.
NCT01364779 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01364779 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.
Primary Outcome
Blood drawn for the Accumetric test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-03 |
What the finished NCT01364779 record still lists
NCT01364779 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01364779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01364779 about?
NCT01364779 is a clinical study titled "Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients". The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.
What is the current status of trial NCT01364779?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2010-04. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT01364779?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia